Cargando…
Alzheimer's Disease: cholesterol, membrane rafts, isoprenoids and statins
Alzheimer's disease (AD) is a heterogeneous neurodegenerative disorder and the most prevalent form of dementia worldwide. AD is characterized pathologically by amyloid-β plaques, neurofibrillary tangles and neuronal loss, and clinically by a progressive loss of cognitive abilities. At present,...
Autores principales: | Reid, Patrick C, Urano, Yasuomi, Kodama, Tatsuhiko, Hamakubo, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922347/ https://www.ncbi.nlm.nih.gov/pubmed/17635634 http://dx.doi.org/10.1111/j.1582-4934.2007.00054.x |
Ejemplares similares
-
Soft X-ray Laser Microscopy of Lipid Rafts towards GPCR-Based Drug Discovery Using Time-Resolved FRET Spectroscopy
por: Baba, Motoyoshi, et al.
Publicado: (2011) -
Cholesterol‐enriched membrane rafts and insulin secretion
por: Dirkx Jr, Ronald, et al.
Publicado: (2012) -
Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005) -
Impact of oxLDL on Cholesterol-Rich Membrane Rafts
por: Levitan, Irena, et al.
Publicado: (2011) -
A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
por: Sakihama, Toshiko, et al.
Publicado: (2008)